MedPlast invests in high-end niche

By Roger Renstrom
Correspondent

Published: March 26, 2013 2:29 pm ET
Updated: March 26, 2013 2:33 pm ET

Image By: Roger Renstrom From left, MedPlast's Matthew Langdon, Harold Faig and Barbara Glenn

Related to this story

Topics Medical, Injection Molding

ANAHEIM, CALIF. — MedPlast Inc. continues to evolve as a diverse, vertically integrated, custom plastics processor for health-care and commercial markets.

The Tempe, Ariz.-based firm — which operates 14 facilities in the U.S., China and Mexico — invests about $5 million a year in plants and equipment, according to CEO Harold Faig.

In March, MedPlast fired up two new Aoki four-cavity injection stretch blow molding machines at its medical-certified site in Tijuana, Mexico — an equipment investment of more than $1 million.

Faig said the company must address changes in the demand for high regulatory compliance while creating value-added products.

"We are building our requirements around capabilities to manufacture things no one else wants to do," he said. MedPlast encourages customers to "give us your difficult products," Faig said in a Feb. 13 interview at the Medical Design & Manufacturing West trade show in Anaheim.

The company projects 2013 sales "north of $250 million," after recording $222 million last year, Faig said. That sales growth will come from existing business as well as new opportunities, according to Matthew Langdon, executive vice president of sales and marketing.

In various locations, MedPlast has thermoplastic, silicone and rubber molding capabilities, and the firm can package, sterilize and ship to destination, Faig said.

In all, MedPlast operates more than 400 presses for injection molding and blow molding. In the U.S., Faig claims that no other firm offers extrusion blow molding, injection blow molding and injection stretch blow molding. "Med­- Plast has more two-shot capability than anyone else [in the U.S.] and more kinds of two-shot capability than anyone else," Faig said. Most of that capability is for health-care work, he added.

For injection molding, MedPlast presses have clamping forces of 3-1,000 tons, though most are in the 50- to 400-ton range, Faig said.

"As we added plants, we needed to be an extension of our customers' manufacturing processes," Faig said.

"Customers want integrated capabilities," Langdon said.

A customer project that has been two years in development at MedPlast's West Berlin, N.J., facility is currently undergoing clinical reviews. MedPlast performed finite analysis, did design-for-manufacturability work, created the tool and molded the top piece of a knee replacement using medical-grade polyetheretherketone.

"They wanted a net shape on the finished part," Faig said. The knee-replacement part bolts to a titanium plate and rod.

Later this year MedPlast expects to receive permission from China's State Food and Drug Administration for a bioburden testing laboratory there. The firm first applied for authorization in 2011.

Also during 2013, MedPlast is transferring some of its technological capabilities to Suzhou, China, to complement production at its elastomer-focused plant in Elkhorn, Wis. The firm moved two injection blow molding machines in the first quarter, and plans to transfer Elkhorn capabilities for two-shot molding and silicone molding during the third quarter. While sharing knowledge, the Elkhorn plant remains busy with significant production volumes, according to Faig.

Baird Capital Partners of Chicago owns the majority share of MedPlast; management owns about 20 percent.

Private equity investors include River Cities Capital Funds of Cincinnati and the Chicago office of Jordan Co. LP.

Last year MedPlast and its investors acquired fellow contract manufacturer United Plastics Group Inc. of Oak Brook, Ill., adding significant reach and production capacity in China — as well as Langdon, who was with UPG for 10 years.

MedPlast completed a restructuring of the UPG operations in November, with the MedPlast brand concentrating on the medical business in nine plants and the UPG brand on specialty industrial markets in five plants.

MedPlast was formed in 2008 from a combination of two Baird acquisitions: Wayne, Pa.-based Applied Tech Products Corp.'s engineered rubber and plastics group and K&W Medical Specialties of Westfield, Pa. Baird is the U.S.-based buyout fund of Baird Private Equity, an affiliate of Robert W. Baird & Co.

Faig, a longtime member of Baird's advisory board, joined MedPlast as CEO. Previously, he was president and CEO of injection molder Tech Group Inc. of Scottsdale, Ariz. He was instrumental in selling Tech Group to West Pharmaceutical Services Inc. in May 2005. Faig had been on Tech's board of directors since 1991.

Faig retired from Milacron Inc. in August 2003 after a long career with the Cincinnati-based plastics equipment maker. He was Milacron's president and chief operating officer.

Faig said that in assembling MedPlast operations, he pursued a strategy of grouping the plants in North America. "We wanted to serve the geographic concentrations for health care," he said.

MedPlast's Northeast facilities are in West Berlin; Westfield; and Chicopee, Mass. Central sites are Elkhorn; Monticello, Iowa; Minneapolis; and Houston. Western sites are Tempe; Tijuana; and Fremont, Calif. Four plants are in China.

Among the acquired UPG assets is mold-making capability in Suzhou. "We moved the UPG mold-making shop to another Suzhou building to consolidate mold making with medical molding," Faig said. MedPlast makes molds only for medical products and only for internal use, he said.

MedPlast produces high-end, implantable components using exotic biocompatible materials like titanium, cobalt chromium and tantalum in screws, bolts and anchors, and using polymers in pessary and orthopedic devices, ocular plugs and hydrocephalus shunts.

MedPlast employs about 1,700, and in the past year has added more sales support, Faig said.


Comments

MedPlast invests in high-end niche

By Roger Renstrom
Correspondent

Published: March 26, 2013 2:29 pm ET
Updated: March 26, 2013 2:33 pm ET

Post Your Comments


Back to story


More stories

Image

Cambro investing $30.4 million in new N.C. injection molding plant

April 18, 2014 2:36 pm ET

Foodservice products manufacturer Cambro Manufacturing Co. Inc. plans to set up a satellite production and distribution operation in Mebane, N.C., to ...    More

Image

Producers urge booming Brazilian housing market to use EPS

April 18, 2014 1:08 pm ET

Leaders in Brazil's plastics industry are asking lawmakers to mandate the use of expandable polystyrene (the raw material for expanded EPS) in new...    More

Image

Increased orders prompt Georg Utz to add capacity, equipment in Indiana

April 18, 2014 12:20 pm ET

Plastic totes and tray orders have picked up to the point where manufacturer Georg Utz Inc. has added machines, silos and material feed systems to...    More

MGS buying N.Y. medical molding plant from Hospira

April 17, 2014 10:19 pm ET

MGS Manufacturing Group is purchasing the Buffalo, N.Y., injection molding facility and related product line of Hospira Inc., effective July 1. Terms ...    More

Image

Navigating the rough seas of selling your company

April 17, 2014 2:47 pm ET

For family owned plastics firms who survived the Great Recession, many wonder: Is it time to sell, retire and sip cocktails on the beach? Or, maybe fi...    More

Market Reports

Thermoformed Packaging 2014 Market Review & Outlook North America

This in-depth report provides analysis and discussions of economic and political conditions, market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as strategies being implemented by thermoformed packaging companies. In addition, there are reviews of 25 leading thermoformers in the packaging segment, assessing their growth initiatives and performance metrics over 10 years.

Learn more

Automotive Market Review and Outlook 2014 The Americas

This 75-page report features in-depth analysis of the automotive industry for the Americas. It includes discussions of market trends, legislative/regulatory activity impacting production and threats as well as design strategies being implemented by the major automakers. Detailed charts and data tables outline North American automotive production over the last five years.

Learn more

Plastics Building & Construction Market Review and Outlook 2014 with MS Excel chart data

This report provides in-depth analysis of the plastic building and construction market for North America, including discussions of trends, opportunities, threats and the latest developments in construction trends that impact plastics processors.

Learn more

Upcoming Plastics News Events

May 6, 2014 - May 8, 2014Plastics in Medical Devices 2014

May 12, 2014 - May 12, 2014Plastics News Brazil Pharma Summit

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

February 3, 2015 - February 7, 2015Plastics News Executive Forum 2015

More Events